In May 2018, a class-action lawsuit was filed against two marketers of the diabetes medication Actos for allegedly misleadingly marketing the drug as safe and effective without disclosing the risks associated with taking the drug, including bladder cancer and congestive heart failure. (Fernandez et al v. Takeda Pharmaceuticals America, Inc. and Eli Lilly & Company, Case No. 18-cv-1142, E.D. Cal.)


The Latest

Filters

Spectrum Mobile

Ad Alert

Spectrum Mobile

Inquiry finds price comparison uses wireless carrier’s lowest tier plan but not one of its competitors.

Brillia

Ad Alert

Brillia

What consumers should know about this purported homeopathic product.


Show More